← All trials
NCT06924762
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 19, 2025
- Primary completion
- Dec 31, 2025
- Completion date
- May 31, 2026
- First posted
- Apr 11, 2025
- Last posted
- Apr 11, 2025
- Enrollment
- 124
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Central South UniversityLead sponsor
- Fujian Medical UniversityCollaborator
- Guangzhou Medical UniversityCollaborator
- Hangzhou Third HospitalCollaborator
- Sun Yat-Sen UniversityCollaborator
- Central South UniversityCollaborator
- Central South UniversityOfficial
- The First People's Hospital of Changde CityCollaborator
- Sichuan UniversityCollaborator
- Central South UniversitySponsor investigator
- Hacettepe UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.